Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma
Australian regulatory agency grants approval to market Alvesco
March 22nd, 2004
Altana AG (AAA; ALT) announced that the Australian Health Agency (TGA) has granted marketing approval for Alvesco (Ciclesonide) a novel inhaled corticosteroid for the treatment of asthma in adults and adolescents 12 years of age and older. This is worldwide the first approval for Alvesco. "Alvesco is an innovative inhaled corticosteroid with unique properties that offer an important treatment option for patients with asthma. The approval of Alvesco is a major milestone for Altana Pharma and we eagerly anticipate making the product available to patients in other important markets as well," said Hans-Joachim Lohrisch, member of the management board of...
Source: Health & Medicine Week (2004-03-22)
|
